This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Big-Volume Stocks Surging Higher

Repros Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Repros Therapeutics (RPRX) is a development-stage biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. This stock is trading up 11.2% at $10.60 in recent trading.

Today's Volume: 431,000

Average Volume: 218,202

Volume % Change: 355%

From a technical perspective, RPRX is skyrocketing today with heavy volume, and this move has pushed the stock into breakout territory since it's taken out some near-term overhead resistance levels at $9.58 to $9.94.

>>5 Biotech Stocks Under $5 Blasting Off

Traders should now look for long-biased trades in RPRX as long as its trending above today's low of $9.53 with strong upside volume flows. I would consider any upside volume day that registers near or above 218,202 shares as bullish. If we continue to see RPRX hold that trend, then this stock could easily be setting up to trade higher towards $15 a share in the near future.

On the flipside, I would avoid this stock or look for short-biased trades if it fails to hold this breakout, and then drops back below some major near-term support at $8.79 with high volume.
2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FRAN $13.47 0.00%
ISBC $12.30 0.00%
RPRX $7.15 0.00%
AFFY $0.10 -5.00%
FB $86.76 1.20%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.11 +5.47 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs